Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$40,334,435
+$9,993,983 QoQ
Shares Held
33,628
+1.9% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#611
of 4,621 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $130,004,533 across 10 Drug Manufacturers - General names. LLY ranks #1 (31.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
33,628 | $40,334,435 | |
| 2 | JNJ |
Johnson & Johnson
|
96,594 | $24,531,978 | |
| 3 | MRK |
Merck & Co., Inc.
|
176,844 | $22,724,454 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
119,118 | $15,049,368 | |
| 5 | BIIB |
Biogen Inc.
|
46,536 | $10,054,568 | |
| 6 | OGN |
Organon & Co.
|
575,000 | $7,785,500 | |
| 7 | ABBV |
AbbVie Inc.
|
25,497 | $6,416,065 | |
| 8 | AZN |
Astrazeneca PLC
|
13,330 | $2,527,634 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,334,435 | 33,628 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $30,340,452 | 32,987 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $44,461,665 | 41,372 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $22,320,039 | 29,253 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $34,083,390 | 43,723 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $30,627,220 | 37,083 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $24,598,236 | 31,863 | Shares | Sole | 2025-04-02 | |
| 2024-09-30 | $36,693,862 | 41,418 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $41,871,108 | 46,247 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $37,549,795 | 48,267 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $28,694,819 | 49,226 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $33,226,324 | 61,859 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $32,897,540 | 70,147 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $27,042,951 | 78,746 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $28,868,800 | 78,911 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $26,408,964 | 81,673 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $29,169,351 | 89,965 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $27,582,299 | 96,317 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $28,719,974 | 103,975 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $22,175,023 | 95,975 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $21,346,507 | 93,005 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $13,423,017 | 71,850 | Shares | Sole | 2021-05-14 | |
| 2020-03-31 | $1,145,133 | 8,255 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||